DK89697A - Anvendelse af melatonin til behandling af patienter, der lider af medikamentafhængighed - Google Patents

Anvendelse af melatonin til behandling af patienter, der lider af medikamentafhængighed Download PDF

Info

Publication number
DK89697A
DK89697A DK089697A DK89697A DK89697A DK 89697 A DK89697 A DK 89697A DK 089697 A DK089697 A DK 089697A DK 89697 A DK89697 A DK 89697A DK 89697 A DK89697 A DK 89697A
Authority
DK
Denmark
Prior art keywords
melatonin
patients suffering
treat patients
drug dependence
dependence
Prior art date
Application number
DK089697A
Other languages
English (en)
Other versions
DK176081B1 (da
Inventor
Nava Zisapel
Original Assignee
Neurim Pharma 1991
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/381,535 external-priority patent/US6469044B1/en
Application filed by Neurim Pharma 1991 filed Critical Neurim Pharma 1991
Publication of DK89697A publication Critical patent/DK89697A/da
Application granted granted Critical
Publication of DK176081B1 publication Critical patent/DK176081B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Toxicology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK199700896A 1995-02-01 1997-07-30 Anvendelse af melatonin til behandling af patienter, der lider af medikamentafhængighed DK176081B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US08/381,535 US6469044B1 (en) 1995-02-01 1995-02-01 Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies
US38153595 1995-02-01
EP95303853A EP0724878B1 (en) 1995-02-01 1995-06-06 Use of melatonin for treating patients suffering from drug dependencies
EP95303853 1995-06-06
PCT/IB1996/000082 WO1996023496A1 (en) 1995-02-01 1996-01-29 Use of melatonin for treating patients suffering from drug addiction
IB9600082 1996-01-29

Publications (2)

Publication Number Publication Date
DK89697A true DK89697A (da) 1997-07-30
DK176081B1 DK176081B1 (da) 2006-04-18

Family

ID=26140195

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199700896A DK176081B1 (da) 1995-02-01 1997-07-30 Anvendelse af melatonin til behandling af patienter, der lider af medikamentafhængighed

Country Status (22)

Country Link
JP (1) JP4516159B2 (da)
CN (1) CN1083263C (da)
AT (1) AT408188B (da)
AU (1) AU695366B2 (da)
BG (1) BG62876B1 (da)
BR (1) BR9607169A (da)
CZ (1) CZ291349B6 (da)
DK (1) DK176081B1 (da)
EE (1) EE03384B1 (da)
FI (1) FI119586B (da)
IS (1) IS1980B (da)
LU (1) LU90118B1 (da)
LV (1) LV11940B (da)
MD (1) MD1716C2 (da)
NO (1) NO312814B1 (da)
NZ (1) NZ298878A (da)
PL (1) PL183148B1 (da)
SI (1) SI9620022A (da)
SK (1) SK284521B6 (da)
TR (1) TR199700723T1 (da)
TW (1) TW483757B (da)
WO (1) WO1996023496A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL150190A0 (en) 2000-01-05 2002-12-01 Neurim Pharma 1991 Method and formulation for treating resistance to antihypertensives and related conditions
IL149377A (en) * 2002-04-28 2012-10-31 Neurim Pharma 1991 Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds
IL155666A (en) 2003-04-29 2013-12-31 Neurim Pharma 1991 Insomnia treatment
US9119846B2 (en) 2003-04-29 2015-09-01 Neurim Pharmaceuticals (1991) Ltd. Method and composition for enhancing cognition in alzheimer's patients
EP4502609A3 (en) 2012-01-26 2025-04-09 Vanda Pharmaceuticals Inc. Determining a circadian rhythm
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
ES2805376T3 (es) 2012-12-18 2021-02-11 Vanda Pharmaceuticals Inc Tasimelteón para el tratamiento de trastornos del ritmo circadiano
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
CN109922795B (zh) * 2016-10-31 2021-10-08 纽里姆药物有限公司 褪黑素小片剂及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69229490T2 (de) * 1991-05-09 2000-02-17 Neurim Pharmaceuticals (1991) Ltd., Tel Aviv Melatonin enthaltende Arzneimittel
IT1251544B (it) * 1991-05-13 1995-05-17 Gabriele Biella Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico

Also Published As

Publication number Publication date
FI973185A0 (fi) 1997-07-31
NO312814B1 (no) 2002-07-08
MD1716B2 (en) 2001-08-31
SK284521B6 (sk) 2005-05-05
BG101803A (en) 1998-04-30
FI973185L (fi) 1997-09-30
SK103097A3 (en) 1998-01-14
IS4532A (is) 1997-07-25
AU695366B2 (en) 1998-08-13
FI119586B (fi) 2009-01-15
CZ240597A3 (cs) 1998-01-14
BG62876B1 (bg) 2000-10-31
AU4457496A (en) 1996-08-21
LV11940B (en) 1998-05-20
LV11940A (lv) 1998-01-20
NO973531D0 (no) 1997-07-31
WO1996023496A1 (en) 1996-08-08
AT408188B (de) 2001-09-25
BR9607169A (pt) 1997-11-11
NO973531L (no) 1997-09-30
PL321630A1 (en) 1997-12-08
DK176081B1 (da) 2006-04-18
PL183148B1 (pl) 2002-05-31
MD970254A (en) 1999-05-31
JPH10513177A (ja) 1998-12-15
CN1083263C (zh) 2002-04-24
TR199700723T1 (xx) 1998-02-21
CZ291349B6 (cs) 2003-02-12
NZ298878A (en) 1999-05-28
MD1716C2 (ro) 2002-02-28
TW483757B (en) 2002-04-21
SI9620022A (sl) 1998-10-31
EE9700166A (et) 1998-02-16
EE03384B1 (et) 2001-04-16
ATA901396A (de) 2001-02-15
JP4516159B2 (ja) 2010-08-04
LU90118B1 (fr) 1997-11-13
IS1980B (is) 2005-01-14
CN1172431A (zh) 1998-02-04
MX9705856A (es) 1998-07-31

Similar Documents

Publication Publication Date Title
DK0941103T3 (da) Farmaceutisk præparat til behandling af diabetes
DK0730864T3 (da) Lægemiddel til behandling af inflammatoriske hjertesygdomme
DK0861081T3 (da) Anvendelse af epinastin til behandling af smerter
ATE235481T1 (de) Substituierte benzopyranderivate zur behandlung von entzündungen
DK0769947T3 (da) Indolinonforbindelser til behandling af sygdom
IS5113A (is) Notkun antagónista CB1-viðtaka til meðhöndlunar löngunartruflana
NO20001479L (no) Behandling av atferdsforstyrrelse
ID26861A (id) Terapi gabungan untuk pengobatan depresi refaktori
DK89697A (da) Anvendelse af melatonin til behandling af patienter, der lider af medikamentafhængighed
DE69620691D1 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
NO975718D0 (no) Behandling av insulinresistens
FI973023L (fi) Liikakasvusairauksien yhdistetty terapeuttinen hoito
NO995231D0 (no) Terapeutisk behandling av hudlidelser
EE200000391A (et) Triasiiniühendid kesknärvisüsteemihäirete raviks
DE69916488D1 (de) Substituierte caprolactam-derivate, diese enthaltende pharmazeutische zubereitungen sowie ihre verwendung zur behandlung von tumoren
NO20015738L (no) Terapeutisk bruk av melatonin
NO981564L (no) Terapeutisk administrering av hemoglobin ved hjertestans
NO981866L (no) Terapeutisk anvendelse av hemoglobin for Õ fremme sÕrheling
NO982562D0 (no) Sammensetning for behandling av smerte
DK0866699T3 (da) Anvendelse af cholinesteraseinhibitorer til fremstilling af et medikament til behandling af xerostomi
NO984651L (no) Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet
NO20001894L (no) Anvendelse av TNF-antagonister som medikamenter for behandling av septiske sykdommer
ID24922A (id) Terapi kombinasi untuk pengobatan aids
FR2702211B1 (fr) Nouveaux dérivés de la phénoxy-2 éthylamine, leur préparation et leur application en thérapeutique.
DK0984787T3 (da) Anvendelse af lavmolekylære hepariner til forebyggelse og behandling af hjerneødemer

Legal Events

Date Code Title Description
PUP Patent expired

Expiry date: 20170730